Merck and Co

Merck buys SpringWorks Therapeutics for $3.9 B to accelerate sustainable growth of healthcare biz BioSpectrum Asia13:01Germany Pharma Biotechnology

Germany's Merck seals US$3.9bln Deal to buy US biotech firm SpringWorks Bernama11:50Germany Pharma Biotechnology

Merck to invest $1 bn in new Delaware plant to boost US manufacturing The Business Standard12:30Delaware Business Delaware Pharma

International company news in brief: Porsche to up US prices Financial Mail13:29Delaware Business Delaware Pharma

German Merck enters US rare tumor market with $3.9B deal Daily Sabah22:30Merck Pharma Germany

German pharma firm Merck to acquire US-based SpringWorks Therapeutics for $3.9B Anadolu Agency15:26Merck Pharma Germany

Earnings update: Merck & Co., Inc. (NYSE:MRK) just reported its first-quarter results and analysts are updating their… Simply Wall St16:22Stock Markets (World) Stock Market (US) Stock Market

Merck Q1 earnings & sales beat estimates, '25 EPS outlook cut Zacks20:24Merck Pharma Currency Markets

Merck's Q1 earnings beat Wall Street, adjusts 2025 profit outlook as tariffs may result in incremental cost of $200… Benzinga16:06Merck Pharma Currency Markets

Merck lowers profit outlook due to expected $200M tariff hit Proactive Investors (US)15:53Pharma Tariffs Stock Market

Merck posts higher profit, puts tariffs cost at $200 million Yahoo! US11:40Pharma Tariffs Stock Market

Merck KGaA strikes $3.9bn deal for SpringWorks Pharmaceutical Technology14:47Pharma

Merck faces patent lawsuit over easier-to-use Keytruda Insurance Claims Journal06:06Insurance (World) Biotechnology Pharma

Merck faces lawsuit to block launch of easier-to-use Keytruda Bloomberg Law14:30Insurance (World) Biotechnology Pharma

Drug firm Merck says existing Trump tariffs will cost it $200m this year Yahoo! UK & Ireland14:46Pharma Tariffs Tax

Pembrolizumab before, after surgery improves head and neck cancer outcomes: Ravindra uppaluri, MD, PhD American Journal of Managed Care18:07Cancer Treatment Cancer Pharma

Latest News

In the last 4 hours

Merck plans to move manufacturing of its biggest drug, Keytruda, to a new US factory and lab in Delaware Lexington Herald-Leader, Kentucky23:08 29-Apr-25

In the last 6 hours

Merck KGaA to Acquire SpringWorks for $3.9B, Expanding Rare Cancer Footprint Genetic Engineering and Biotechnology News21:34 29-Apr-25

In the last 8 hours

Merck Breaks Ground On New Biologics And ADC Manufacturing Facility In Delaware Pharmaceutical Online20:40 29-Apr-25

Yesterday

Merck plans to shift Keytruda production to the US ENDPOINTS16:47 29-Apr-25

Merck begins construction on $1B Keytruda manufacturing facility in Delaware FiercePharma14:57 29-Apr-25

Merck to build new $1B biologics manufacturing facility in Wilmington, Delaware Fox News14:29 29-Apr-25

Merck to invest $1 billion in U.S. drug manufacturing plant CBS News14:19 29-Apr-25

Merck Has a $1B Plan to Avoid Tariffs TipRanks13:49 29-Apr-25

International company news in brief: Porsche to up US prices Financial Mail13:29 29-Apr-25

Stock Watch: Sanofi, Merck Open Windows Into Geopolitical Risks Scrip Pharma Intelligence12:35 29-Apr-25

Merck to invest $1 bn in new Delaware plant to boost US manufacturing The Business Standard12:30 29-Apr-25

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware Business Wire (Press Release)11:52 29-Apr-25

Merck to invest $1 billion in new Delaware plant to boost US manufacturing, WSJ reports Yahoo! US11:12 29-Apr-25

In the last 7 days

German Merck enters US rare tumor market with $3.9B deal Daily Sabah22:30 28-Apr-25

Merck Set To Add Perioperative Head-And-Neck Cancer To Keytruda Label Scrip Pharma Intelligence22:18 28-Apr-25

Merck & Co. CMO Eliav Barr Assures On Pipeline As Keytruda LOE Looms Large Scrip Pharma Intelligence22:18 28-Apr-25

Merck KGaA to buy cancer biotech SpringWorks for $3.9 billion Chemical & Engineering News21:44 28-Apr-25

Shock value: Merck’s $3.9B Springworks grab provides jolt BioWorld21:11 28-Apr-25

AACR: Merck's Keytruda prevents head and neck cancer from returning in industry-first win FiercePharma18:37 28-Apr-25

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion Benzinga17:32 28-Apr-25

Merck KGaA to buy biotech SpringWorks for $3.9B BioPharma Dive16:54 28-Apr-25

Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks FiercePharma16:35 28-Apr-25

Merck to buy US biotech SpringWorks for $3.9bn ShareCast16:34 28-Apr-25

Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its First-Quarter Results And Analysts Are Updating Their… Simply Wall St16:22 28-Apr-25

Temu, Tesla prices, Merck KGaA deal: Trending Tickers Yahoo! UK & Ireland15:43 28-Apr-25

German pharma firm Merck to acquire US-based SpringWorks Therapeutics for $3.9B Anadolu Agency15:26 28-Apr-25

Merck KGaA strikes $3.9bn deal for SpringWorks Pharmaceutical Technology14:47 28-Apr-25

Merck sued over world’s best-selling drug as rivalry between patent licensors heats up IAM14:35 28-Apr-25

Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat? Zacks13:59 28-Apr-25

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B ENDPOINTS13:29 28-Apr-25

Sullivan & Cromwell-Led Merck To Buy SpringWorks For $3.9B Law36013:15 28-Apr-25

Merck buys SpringWorks Therapeutics for $3.9 B to accelerate sustainable growth of healthcare biz BioSpectrum Asia13:01 28-Apr-25

Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B Yahoo! US12:45 28-Apr-25

M&A News: Merck Stock (MRK) Climbs as $3.9B SpringWorks deal creates ‘Tech Powerhouse’ TipRanks12:34 28-Apr-25

Merck KGaA expands rare tumour portfolio with $3.9bn SpringWorks acquisition PMLiVE12:29 28-Apr-25

SWTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SpringWorks… Business Wire (Press Release)11:59 28-Apr-25

Germany's Merck Seals US$3.9bln Deal To Buy US Biotech Firm Springworks Bernama11:50 28-Apr-25

SpringWorks Therapeutics Merges with Merck for $3.9 Billion TipRanks11:33 28-Apr-25

Merck KGaA to Buy US Biotech Springworks for $3.9 Billion (2) Bloomberg Law10:18 28-Apr-25

Merck agrees $3.9 billion takeover of SpringWorks pharmaphorum10:13 28-Apr-25

UPDATED: Merck KGaA Seals SpringWorks Buy Scrip Pharma Intelligence09:35 28-Apr-25

Merck KGaA swoops for US group SpringWorks in $3.4bn deal Proactive Investors (UK)07:58 28-Apr-25

Merck to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate ... Merck Group (Press Release)07:39 28-Apr-25

Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks Yahoo! US07:29 28-Apr-25

Germany's Merck KGaA in $3.9 billion deal to acquire US biotech firm SpringWorks Yahoo! UK & Ireland07:25 28-Apr-25

Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare… GlobeNewswire (Press Release)07:22 28-Apr-25

Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to… Business Wire (Press Release)07:16 28-Apr-25

Pembrolizumab Before, After Surgery Improves Head and Neck Cancer Outcomes: Ravindra Uppaluri, MD, PhD American Journal of Managed Care18:07 27-Apr-25

Merck’s Earnings Call: Growth Potential and Challenges TipRanks01:25 26-Apr-25

Merck Annual General Meeting Approves All Agenda Items Merck Group (Press Release)23:01 25-Apr-25

Merck Stays Confident On M&A Despite Market Uncertainty: Analyst Benzinga21:09 25-Apr-25

Pharma giant Merck expects Trump’s tariffs to cost the company $200 million Fortune19:15 25-Apr-25

Merck KGaA nears $3.5bn deal for SpringWorks Pharmaceutical Technology18:07 25-Apr-25

Merck KGaA Moves Closer To Sealing SpringWorks Buy Scrip Pharma Intelligence16:37 25-Apr-25

Merck Foundation marks World Health Day through their 2250+ Medical Scholarships in 44 Critical … African Press Organization16:16 25-Apr-25

Merck cuts several Phase 2 programs; Vyne’s Phase 1b psoriasis trial put on clinical hold ENDPOINTS15:32 25-Apr-25

Merck KGaA confirms late-stage talks with SpringWorks about $3.5B buyout FiercePharma13:21 25-Apr-25

Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20 Simply Wall St12:58 25-Apr-25

Merck KGaA closes in on SpringWorks deal at $3.5B price point ENDPOINTS11:48 25-Apr-25

Kenya: Merck Launches ThyroAfrica Campaign in Kenya to Tackle Thyroid Disorders Ahead of World Thyroid Day AllAfrica11:14 25-Apr-25

Merck puts a price on its SpringWorks takeover bid pharmaphorum09:30 25-Apr-25

M&A News: Merck KGaA to Buy SpringWorks for $3.5B to Boost Oncology Business TipRanks06:14 25-Apr-25

Merck Faces Patent Lawsuit Over Easier-to-Use Keytruda Insurance Claims Journal06:06 25-Apr-25

Merck Reports Mixed Q1 2025 Financial Results TipRanks05:13 25-Apr-25

Merck Forecast Incorporates $200m Tariff Hit Scrip Pharma Intelligence23:28 24-Apr-25

Germany's Merck nears deal for SpringWorks, source says Yahoo! US20:29 24-Apr-25

Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut Zacks20:24 24-Apr-25

Merck is well-stocked on Keytruda as pharma tariffs loom, CEO says ENDPOINTS20:22 24-Apr-25

Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through FiercePharma20:14 24-Apr-25

Merck warns of big tariff hit, Hasbro soars, Comcast sinks Yahoo! UK & Ireland18:29 24-Apr-25

Halozyme launches patent fight over Merck's injectable Keytruda ENDPOINTS18:00 24-Apr-25

Merck ‘willing to work’ with Trump administration on price gap between US, international… FiercePharma17:02 24-Apr-25

Senator Dr. Rasha Kelej, Chief Executive Officer (CEO) of Merck Foundation, Featured by Vogue… African Press Organization16:50 24-Apr-25

Merck takes $200M tariff hit, trimming its gross profits BioPharma Dive16:48 24-Apr-25

Curiosity Cube 2025: Merck’s Mobile Science ... Merck Group (Press Release)16:41 24-Apr-25

Merck (MRK) Reports Q1 Earnings: What Key Metrics Have to Say Zacks16:30 24-Apr-25

Merck's Q1 Earnings Beat Wall Street, Adjusts 2025 Profit Outlook As Tariffs May Result In Incremental Cost Of $200… Benzinga16:06 24-Apr-25

Merck lowers profit outlook due to expected $200M tariff hit Proactive Investors (US)15:53 24-Apr-25

Drug firm Merck says existing Trump tariffs will cost it $200m this year Yahoo! UK & Ireland14:46 24-Apr-25

Merck, Nokia, Texas Instruments: Trending Tickers Yahoo! UK & Ireland14:46 24-Apr-25

Merck Q1 Profit Tops Estimates; Trims FY25 Adj. EPS Outlook RTT News14:32 24-Apr-25

Merck Faces Lawsuit to Block Launch of Easier-to-Use Keytruda Bloomberg Law14:30 24-Apr-25

Google, Merck, PepsiCo, Procter & Gamble: Stocks to watch today Quartz14:14 24-Apr-25

Merck (MRK) Q1 Earnings and Revenues Top Estimates Zacks13:47 24-Apr-25

MRK Earnings: Merck & Company Fears $200M Tariff Hit but Pet Drugs Give Bite to Q1 Sales TipRanks13:46 24-Apr-25

Halozyme Sues Merck for Patent Infringement over Subcutaneous Keytruda Formulation PR Newswire (Press Release)13:31 24-Apr-25

Gilead shares promising phase 3 results for Trodelvy plus Keytruda in aggressive breast cancer PMLiVE12:24 24-Apr-25

Merck posts higher profit, puts tariffs cost at $200m RTE12:16 24-Apr-25

Merck Trims FY25 Adj. EPS Outlook - Update RTT News12:05 24-Apr-25

Merck posts higher profit, puts tariffs cost at $200 million Yahoo! US11:40 24-Apr-25

Merck Q1 earnings: Gardasil sales hit by China market pressure ENDPOINTS11:32 24-Apr-25

Merck Announces First-Quarter 2025 Financial Results Business Wire (Press Release)11:30 24-Apr-25

Merck Stock Slumps Ahead Of Q1 Earnings: Can Bulls Find Relief In Buying Pressure? Benzinga20:00 23-Apr-25

Merck Foundation Chief Executive Officer (CEO) meets the 125 Winners from 36 Countries- “More… African Press Organization17:24 23-Apr-25

The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi Zacks15:34 23-Apr-25

Incretin-based Drugs Market Forecast Report 2025-2034 Featuring AstraZeneca, Boehringer… Business Wire (Press Release)15:27 23-Apr-25

Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings Barchart13:51 23-Apr-25

In the last month

Merck Q1 Earnings Coming Up: Should You Buy the Stock Now? Zacks13:37 22-Apr-25

Lipid-Based Pharma Excipients Market Global Outlook 2025-2030, with Key Vendor Profiles for Abf Ingredients - Abitec,… GlobeNewswire (Press Release)09:09 22-Apr-25

Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc JD Supra02:01 22-Apr-25

Top-Selling Drugs 2024: Keytruda, Ozempic And Dupixent Dominate Scrip Pharma Intelligence20:47 21-Apr-25

Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer Benzinga20:13 21-Apr-25

United States Pain Management Therapeutics Market Forecast Report and Company Analysis 2025-2033 Featuring Eli Lilly… GlobeNewswire (Press Release)16:33 21-Apr-25

Streak Analysis Alert: Why Merck (MRK) Should Be on Your Radar This Week Barchart15:20 19-Apr-25

Ahead of Merck (MRK) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics Zacks15:29 18-Apr-25

Merck alert: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and… GlobeNewswire (Press Release)02:16 18-Apr-25

Merck Foundation Chief Executive Officer (CEO) in partnership with African First Ladies… African Press Organization16:15 17-Apr-25

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock Zacks15:13 17-Apr-25

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or… Business Wire (Press Release)13:01 17-Apr-25

Artificial Intelligence (AI) In Animal Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,… GlobeNewswire (Press Release)12:28 17-Apr-25

Microfiltration Membranes Market Research - Global Forecast to 2029 with Merck, Sartorius, and Pall Leading GlobeNewswire (Press Release)11:07 17-Apr-25

See Which Of The Latest 13F Filers Holds MRK Nasdaq17:10 16-Apr-25

Merck and Cyprumed enter oral peptide partnership worth over $493m PMLiVE12:42 16-Apr-25

Cyprumed, Merck ink $493M peptide pill licensing deal BioWorld21:34 15-Apr-25

Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet-Based Peptide Delivery Benzinga20:40 15-Apr-25

view more headlines

29 Apr 23:08

Merck & Co News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Merck & Co news, covering the latest MSD share price, Merck Sharp & Dohme company announcements, product trials, pharmaceutical news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.